Allogeneic Hematopoietic Stem Cell Transplantation for the Treatment of High-Risk Acute Myelogenous Leukemia and Myelodysplastic Syndrome Using Reduced-Intensity Conditioning with Fludarabine and Melphalan

Reduced-intensity conditioning has extended the use of allogeneic hematopoietic stem cell transplantation (HSCT) to patients otherwise not eligible for this treatment due to older age or frailty. One hundred twelve acute myelogenous leukemia/myelodysplastic syndromes patients received fludarabine an...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Oran, Betul, Giralt, Sergio, Saliba, Rima, Hosing, Chitra, Popat, Uday, Khouri, Issa, Couriel, Daniel, Qazilbash, Muzaffar, Anderlini, Paolo, Kebriaei, Partow, Ghosh, Shubhra, Carrasco-Yalan, Antonio, de Meis, Ernesto, Anagnostopoulos, Athanasios, Donato, Michele, Champlin, Richard E., de Lima, Marcos
פורמט: Artigo
שפה:Inglês
יצא לאור: 2007
נושאים:
Article
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC4080636/
https://ncbi.nlm.nih.gov/pubmed/17382251
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2006.11.024
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים